Govt panel recommends against allowing SII to conduct trial of Covovax on children aged 2-17 yrs

An expert panel of the country's central drug authority on Wednesday recommended against granting permission to the Serum Institute of India (SII) to conduct the phase 2/3 trial of Covid-19 vaccine Covovax on children aged two to 17 years, sources said.